marketcaparena
Search

    KIDS

    ORTHOPEDIATRICS CORP

    Company overview

    Market capitalization
    $589.56M
    Employees
    602
    Latest publication
    2026-09-29
    About ORTHOPEDIATRICS CORP

    OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity in children; and sports medicine and other products. Its products comprise PediLoc, PediPlates, cannulated screws, PediFlex nail, PediNail, PediLoc Tibia, ACL Reconstruction System, Locking Cannulated Blade, Locking Proximal Femur, Spica Tables, RESPONSE Spine, BandLoc, Pediatric Nailing Platform | Femur, Devise Rail, Orthex, The Fassier-Duval Telescopic Intramedullary System, SLIM Nail, The GAP Nail, The Free Gliding SCFE Screw System, GIRO Growth Modulation System, PNP Tibia System, ApiFix Mid-C System, Mitchell Ponseti, VerteGlideTM, and Boston Brace 3D. The company serves pediatric orthopedic market, as well as pediatric orthopedic surgeons and caregivers. OrthoPediatrics Corp. was founded in 2006 and is headquartered in Warsaw, Indiana.

    Company website

    Financial statements

    Income Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USDQ3 20172017-09-30 · USDQ2 20172017-06-30 · USDQ1 20172017-03-31 · USDQ3 20162016-09-30 · USDQ4 20152015-12-31 · USDQ4 20142014-12-31 · USD
    Total Revenue70,508,000USD12,375,000USD11,802,000USD9,762,000USD10,135,000USD31,004,000USD23,684,000USD
    Cost Of Revenue18,142,000USD2,884,000USD3,090,000USD2,347,000USD2,978,000USD9,361,000USD7,079,000USD
    Gross Profit52,366,000USD9,491,000USD8,712,000USD7,415,000USD7,157,000USD21,637,000USD16,599,000USD
    Research Development2,325,000USD1,127,000USD668,000USD687,000USD501,000USD1,789,000USD1,683,000USD
    Selling And Marketing Expenses21,294,000USD5,633,000USD5,299,000USD4,192,000USD4,289,000USD——
    General And Administrative Expenses32,814,000USD——————
    Total Operating Expenses56,434,000USD10,247,000USD9,389,000USD8,252,000USD7,680,000USD37,596,000USD30,828,000USD
    Operating Income-4,068,000USD-756,000USD-677,000USD-837,000USD-523,000USD-6,592,000USD-7,144,000USD
    Total Other Income Expense Net-2,861,000USD-781,000USD-589,000USD-448,000USD-322,000USD-1,261,000USD-2,616,000USD
    Interest Expense2,528,000USD761,000USD650,000USD445,000USD399,000USD1,230,000USD2,549,000USD
    Income Before Tax-6,929,000USD-1,537,000USD-1,266,000USD-1,285,000USD-845,000USD-7,853,000USD-9,760,000USD
    Income Tax Expense234,000USD85,000USD711,000USD442,000USD476,000USD0USD0USD
    Net Income-7,163,000USD-1,537,000USD-1,266,000USD-1,285,000USD-845,000USD-7,891,000USD-9,549,000USD
    Selling General Administrative—3,487,000USD3,422,000USD3,373,000USD2,890,000USD26,381,000USD22,187,000USD
    Net Income From Continuing Ops—-1,537,000USD2,589,000USD-1,285,000USD0USD-7,853,000USD-9,760,000USD
    Ebit—-776,000USD-616,000USD-840,000USD-446,000USD-6,592,000USD-7,144,000USD
    Ebitda—-120,000USD-22,000USD-342,000USD53,000USD——
    Depreciation And Amortization—656,000USD594,000USD498,000USD499,000USD——
    Reconciled Depreciation—656,000USD594,000USD498,000USD499,000USD——
    Non Operating Income Net Other—-20,000USD—————
    Minority Interest—0USD0USD0USD0USD0USD0USD
    Discontinued Operations—0USD0USD0USD0USD-38,000USD211,000USD
    Net Income Applicable To Common Shares—-3,021,000USD5,413,000USD-2,711,000USD0USD-12,688,000USD-12,804,000USD
    Unclassified Operating Expenses—————9,426,000USD6,958,000USD
    SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USDQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USD
    Total Assets511,388,000USD502,190,000USD508,630,000USD493,486,000USD503,606,000USD470,250,000USD473,209,000USD489,294,000USD
    Cash And Equivalents17,001,000USD———————
    Cash And Short Term Investments45,879,000USD50,861,000USD60,851,000USD57,728,000USD70,149,000USD58,772,000USD68,833,000USD76,064,000USD
    Short Term Investments28,878,000USD36,616,000USD41,295,000USD40,902,000USD25,596,000USD25,333,000USD25,013,000USD25,017,000USD
    Total Current Assets252,508,000USD245,866,000USD256,419,000USD245,852,000USD257,702,000USD232,059,000USD237,173,000USD248,312,000USD
    Other Current Assets6,057,000USD6,554,000USD7,940,000USD8,043,000USD8,491,000USD9,542,000USD8,978,000USD8,487,000USD
    Other Non Current Assets15,303,000USD———————
    Total Liabilities167,774,000USD———————
    Total Current Liabilities52,852,000USD47,183,000USD46,197,000USD33,232,000USD38,666,000USD37,505,000USD33,962,000USD34,625,000USD
    Other Current Liabilities13,748,000USD———————
    Other Non Current Liabilities9,192,000USD———————
    Total Stockholder Equity343,614,000USD338,712,000USD346,596,000USD349,309,000USD355,514,000USD347,146,000USD354,566,000USD370,919,000USD
    Total Equity Including Noncontrolling Interest343,614,000USD———————
    Net Receivables60,951,000USD54,430,000USD53,838,000USD51,274,000USD53,797,000USD43,993,000USD42,357,000USD42,827,000USD
    Inventory137,567,000USD134,020,999USD133,790,000USD128,807,000USD125,265,000USD119,752,000USD117,005,000USD120,934,000USD
    Property Plant Equipment Net48,552,000USD48,554,000USD49,555,000USD51,204,000USD52,928,000USD52,622,000USD58,833,000USD61,705,000USD
    Goodwill118,461,000USD———————
    Accounts Payable22,239,000USD19,701,000USD18,786,000USD7,164,000USD12,687,000USD14,199,000USD8,908,000USD11,647,000USD
    Common Stock7,000USD6,000USD6,000USD6,000USD6,000USD6,000USD6,000USD6,000USD
    Retained Earnings-293,062,000USD-285,899,000USD-275,212,000USD-265,109,000USD-253,336,000USD-246,223,000USD-235,564,000USD-219,495,000USD
    Accumulated Other Comprehensive Income3,232,000USD-1,404,000USD-523,000USD-3,629,000USD-4,946,000USD-11,626,000USD-10,773,000USD-6,600,999USD
    Intangible Assets—76,716,000USD77,711,000USD79,203,000USD80,032,000USD79,084,000USD81,179,000USD84,699,000USD
    Total Liab—163,478,000USD162,034,000USD144,177,000USD148,092,000USD123,104,000USD118,643,000USD118,375,000USD
    Other Current Liab—24,552,000USD27,241,000USD25,902,000USD25,815,000USD23,144,000USD22,774,000USD21,047,000USD
    Capital Stock—6,000USD6,000USD6,000USD6,000USD6,000USD6,000USD6,000USD
    Good Will—115,173,000USD109,269,000USD103,613,000USD99,019,000USD93,673,000USD93,844,000USD91,262,000USD
    Other Assets—1USD——————
    Cash—14,245,000USD19,556,000USD16,826,000USD44,553,000USD33,439,000USD43,820,000USD51,047,000USD
    Net Debt—92,033,000USD80,434,000USD82,514,000USD52,615,000USD39,749,000USD37,077,000USD28,197,000USD
    Short Term Debt—2,930,000USD170,000USD166,000USD164,000USD162,000USD2,280,000USD1,931,000USD
    Short Long Term Debt—172,000USD170,000USD166,000USD164,000USD162,000USD160,000USD158,000USD
    Short Long Term Debt Total—106,278,000USD99,990,000USD99,340,000USD97,168,000USD73,188,000USD80,897,000USD79,244,000USD
    Long Term Debt—100,387,000USD99,820,000USD99,174,000USD97,004,000USD73,026,000USD72,956,000USD72,514,000USD
    Common Stock Shares Outstanding—23,685,055shares23,575,945shares23,420,158shares23,346,000shares23,231,000shares23,172,000shares23,171,000shares
    Non Current Assets Total—256,323,999USD252,211,000USD247,634,000USD245,904,000USD238,191,000USD236,036,000USD240,982,000USD
    Non Current Liabilities Total—116,295,000USD115,837,000USD110,945,000USD109,426,000USD85,599,000USD84,681,000USD83,750,000USD
    Non Current Liabilities Other—9,592,000USD9,537,000USD7,740,000USD8,673,000USD6,691,000USD5,892,000USD4,799,000USD
    Non Currrent Assets Other—15,880,999USD15,676,000USD13,614,000USD13,925,000USD12,812,000USD24,989,000USD3,316,000USD
    Net Working Capital—198,683,000USD210,222,000USD212,620,000USD219,036,000USD194,554,000USD203,211,000USD213,687,000USD
    Unclassified Non Current Liabilities—6,316,000USD6,480,000USD4,031,000USD3,749,000USD5,882,000USD5,833,000USD6,437,000USD
    Unclassified Equity—626,003,000USD622,319,000USD618,035,000USD613,784,000USD604,983,000USD600,891,000USD597,002,999USD
    Property Plant Equipment Gross——107,420,000USD———96,713,000USD—
    Unclassified Non Current Assets——————-22,809,000USD—
    SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
    Total Assets508,630,000USD473,209,000USD438,745,000USD427,727,000USD308,402,000USD324,831,000USD194,564,000USD112,105,000USD
    Intangible Assets77,711,000USD81,179,000USD84,562,000USD79,901,000USD69,762,000USD64,245,000USD18,974,000USD2,181,000USD
    Other Current Assets7,940,000USD8,978,000USD5,722,000USD5,437,000USD3,229,000USD2,618,000USD2,714,000USD1,256,000USD
    Total Liab162,034,000USD118,643,000USD61,720,000USD49,079,000USD83,033,000USD90,063,000USD52,203,000USD30,373,000USD
    Total Stockholder Equity346,596,000USD354,566,000USD377,025,000USD378,648,000USD225,369,000USD234,768,000USD142,361,000USD81,732,000USD
    Other Current Liab27,241,000USD22,774,000USD28,865,000USD13,623,000USD7,391,000USD12,626,000USD2,723,000USD5,128,000USD
    Common Stock6,000USD6,000USD6,000USD6,000USD5,000USD5,000USD4,000USD4,000USD
    Capital Stock6,000USD6,000USD6,000USD6,000USD5,000USD5,000USD4,000USD4,000USD
    Retained Earnings-275,212,000USD-235,564,000USD-197,742,000USD-176,768,000USD-178,026,000USD-161,766,000USD-128,822,000USD-115,091,000USD
    Good Will109,269,000USD93,844,000USD83,699,000USD86,821,000USD72,349,000USD70,511,000USD26,183,000USD—
    Cash19,556,000USD43,820,000USD31,055,000USD8,991,000USD9,006,000USD30,132,000USD70,777,000USD60,691,000USD
    Cash And Short Term Investments60,851,000USD68,833,000USD80,306,000USD118,290,000USD54,908,000USD85,273,000USD70,777,000USD60,691,000USD
    Total Current Assets256,419,000USD237,173,000USD226,496,000USD226,719,000USD133,648,000USD158,429,000USD128,058,000USD97,156,000USD
    Total Current Liabilities46,197,000USD33,962,000USD41,666,000USD30,871,000USD29,715,000USD35,028,000USD13,663,000USD9,217,000USD
    Net Debt80,434,000USD37,077,000USD-20,995,000USD-8,084,000USD19,502,000USD-3,617,000USD-44,523,000USD-39,417,000USD
    Short Term Debt170,000USD2,280,000USD152,000USD144,000USD12,999,000USD12,364,000USD124,000USD118,000USD
    Short Long Term Debt170,000USD160,000USD152,000USD144,000USD137,000USD131,000USD124,000USD118,000USD
    Short Long Term Debt Total99,990,000USD80,897,000USD10,060,000USD907,000USD28,508,000USD26,515,000USD26,254,000USD21,274,000USD
    Long Term Debt99,820,000USD72,956,000USD9,908,000USD763,000USD907,000USD1,044,000USD26,067,000USD21,156,000USD
    Short Term Investments41,295,000USD25,013,000USD49,251,000USD109,299,000USD45,902,000USD55,141,000USD——
    Net Receivables53,838,000USD42,357,000USD34,617,000USD24,800,000USD17,942,000USD17,549,000USD16,567,000USD9,501,000USD
    Inventory133,790,000USD117,005,000USD105,851,000USD78,192,000USD57,569,000USD52,989,000USD38,000,000USD25,708,000USD
    Accounts Payable18,786,000USD8,908,000USD12,649,000USD11,150,000USD9,325,000USD10,038,000USD6,467,000USD3,971,000USD
    Property Plant Equipment Net49,555,000USD58,833,000USD41,048,000USD34,286,000USD28,515,000USD27,227,000USD21,349,000USD12,768,000USD
    Property Plant Equipment Gross107,420,000USD96,713,000USD80,636,000USD65,090,000USD51,604,000USD27,227,000USD21,349,000USD12,768,000USD
    Accumulated Other Comprehensive Income-523,000USD-10,773,000USD-5,526,000USD-5,400,000USD8,491,000USD7,907,000USD-3,000USD-623,000USD
    Common Stock Shares Outstanding23,459,425shares23,078,000shares22,675,477shares20,947,727shares19,268,255shares18,056,828shares14,624,194shares12,567,387shares
    Non Current Assets Total252,211,000USD236,036,000USD212,249,000USD201,008,000USD174,754,000USD166,402,000USD66,506,000USD14,949,000USD
    Non Current Liabilities Total115,837,000USD84,681,000USD20,054,000USD18,208,000USD53,318,000USD55,035,000USD38,540,000USD21,156,000USD
    Non Current Liabilities Other9,537,000USD5,892,000USD1,112,000USD18,208,000USD49,190,000USD50,616,000USD38,540,000USD—
    Non Currrent Assets Other15,676,000USD24,989,000USD1,085,000USD-195,476,000USD9,497,000USD-5,755,000USD-54,096,000USD14,949,000USD
    Net Working Capital210,222,000USD203,211,000USD184,830,000USD195,848,000USD103,933,000USD123,401,000USD114,395,000USD87,939,000USD
    Unclassified Non Current Liabilities6,480,000USD5,833,000USD9,034,000USD-17,950,000USD-45,062,000USD-45,874,000USD-26,130,000USD—
    Unclassified Equity622,319,000USD600,891,000USD580,281,000USD560,804,000USD394,894,000USD388,617,000USD271,178,000USD197,438,000USD
    Unclassified Non Current Assets—-22,809,000USD——-5,369,000USD4,405,039USD-2,213,000USD-16,808,000USD
    Other Liab———17,187,000USD48,283,000USD49,249,000USD63,000USD—
    Current Deferred Revenue———5,954,000USD18,213,000USD23,115,000USD4,349,000USD3,552,000USD
    Net Tangible Assets———211,926,000USD83,258,000USD100,012,000USD109,614,000USD79,551,000USD
    Unclassified Current Liabilities————-18,350,000USD-23,246,000USD—-3,670,000USD
    Other Assets—————13,961USD2,213,000USD1,859,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USDQ2 20242024-06-30 · USD
    Net Income-10,687,000USD-10,103,000USD-11,773,000USD-7,113,000USD-10,659,000USD-16,069,000USD-7,919,000USD-6,029,000USD
    Depreciation5,721,000USD5,602,000USD5,299,000USD5,170,000USD5,048,000USD3,993,000USD5,280,000USD4,779,000USD
    Stock Based Compensation3,982,000USD4,416,000USD4,251,000USD5,252,000USD3,859,000USD3,888,000USD3,922,000USD2,939,000USD
    Other Non Cash Items122,000USD2,665,000USD4,182,000USD-203,000USD201,000USD1,988,000USD-22,685,000USD-87,000USD
    Change To Account Receivables-183,000USD-1,096,000USD3,111,000USD-9,884,000USD-1,497,000USD429,000USD-595,000USD-5,738,000USD
    Change To Inventory139,000USD-576,000USD1,006,000USD-6,993,000USD-1,906,000USD957,000USD-3,734,000USD-3,789,000USD
    Change In Working Capital-2,111,000USD8,041,000USD-2,415,000USD-13,617,000USD-2,801,000USD3,042,000USD12,075,000USD-7,527,000USD
    Total Cash From Operating Activities-3,287,000USD10,348,000USD-581,000USD-10,462,000USD-4,156,000USD-3,987,000USD-10,279,000USD-6,435,000USD
    Capital Expenditures-1,760,000USD-599,000USD-2,839,000USD-3,445,000USD-4,227,000USD-262,000USD-1,381,000USD-6,684,000USD
    Free Cash Flow-5,047,000USD9,749,000USD-3,420,000USD-13,907,000USD-8,383,000USD-3,725,000USD-11,660,000USD-13,119,000USD
    Investments4,750,000USD-10,000USD-26,838,000USD-3,545,000USD-5,987,000USD-2,412,000USD-26,768,000USD19,697,000USD
    Total Cashflows From Investing Activities-3,787,000USD-7,259,000USD-26,838,000USD-3,545,000USD-5,987,000USD-2,412,000USD-26,768,000USD19,697,000USD
    Net Borrowings-614,000USD450,000USD-282,000USD24,800,000USD-126,000USD889,000USD61,260,000USD—
    Total Cash From Financing Activities-614,000USD-417,000USD-282,000USD24,800,000USD-126,000USD-541,000USD58,518,000USD-3,926,000USD
    Change In Cash-7,375,000USD2,736,000USD-27,721,000USD11,176,000USD-10,348,000USD-7,268,000USD22,155,000USD7,326,000USD
    Begin Period Cash Flow21,620,000USD18,884,000USD46,605,000USD35,429,000USD45,777,000USD53,045,000USD30,890,000USD23,564,000USD
    End Period Cash Flow14,245,000USD21,620,000USD18,884,000USD46,605,000USD35,429,000USD45,777,000USD53,045,000USD30,890,000USD
    Other Cashflows From Financing Activities-614,000USD-417,000USD-282,000USD24,800,000USD-126,000USD-1,430,000USD343,000USD-3,500,000USD
    Unclassified Investing Cash Flow-6,777,000USD-8,657,000USD3,306,000USD3,445,000USD5,767,000USD—52,091,000USD-19,697,000USD
    Other Cashflows From Investing Activities—2,007,000USD-467,000USD—-1,540,000USD380,000USD-50,710,000USD26,381,000USD
    Unclassified Financing Cash Flow———-24,800,000USD——-3,085,000USD—
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
    Net Income-39,648,000USD-37,822,000USD-20,974,000USD1,258,000USD-16,260,000USD-32,944,000USD-13,731,000USD-12,025,000USD
    Depreciation21,119,000USD19,080,000USD17,385,000USD13,099,000USD10,680,000USD8,010,000USD4,671,000USD2,892,000USD
    Stock Based Compensation17,778,000USD13,548,000USD10,526,000USD6,679,000USD5,842,000USD6,196,000USD2,603,000USD3,185,000USD
    Other Non Cash Items6,845,000USD5,817,000USD-623,000USD-20,014,000USD354,000USD5,917,000USD210,000USD19,095,000USD
    Change To Account Receivables-9,366,000USD-4,749,000USD-9,724,000USD-3,983,000USD-466,000USD-451,000USD-5,820,000USD-3,801,000USD
    Change To Inventory-8,469,000USD-13,197,000USD-26,279,000USD-16,938,000USD-5,050,000USD-12,070,000USD-9,767,000USD-4,801,000USD
    Change In Working Capital-10,792,000USD-22,935,000USD-32,197,000USD-17,756,000USD-12,551,000USD-4,986,000USD-11,378,000USD-9,635,000USD
    Total Cash From Operating Activities-4,851,000USD-27,048,000USD-27,046,000USD-21,766,000USD-13,063,000USD-18,530,000USD-17,769,000USD-15,583,000USD
    Capital Expenditures-11,110,000USD-14,263,000USD-18,984,000USD-10,031,000USD-16,011,000USD-11,300,000USD-12,086,000USD-5,463,000USD
    Free Cash Flow-15,961,000USD-41,311,000USD-46,030,000USD-31,797,000USD-29,074,000USD-29,830,000USD-29,855,000USD-21,046,000USD
    Investments-17,017,000USD-13,162,000USD528,000USD-63,250,000USD9,250,000USD-55,000,000USD-61,922,000USD-502,000USD
    Total Cashflows From Investing Activities-43,629,000USD-13,162,000USD41,677,000USD-113,371,000USD-7,411,000USD-69,693,000USD-61,922,000USD-5,965,000USD
    Net Borrowings24,842,000USD61,150,000USD9,280,000USD-3,371,000USD-131,000USD-25,125,000USD29,882,000USD-4,178,000USD
    Total Cash From Financing Activities23,975,000USD53,135,000USD7,301,000USD135,974,000USD6,000USD46,732,000USD91,019,000USD39,657,000USD
    Change In Cash-24,157,000USD12,750,000USD22,565,000USD1,456,000USD-21,126,000USD-41,895,000USD11,336,000USD18,109,000USD
    Begin Period Cash Flow45,777,000USD33,027,000USD10,462,000USD9,006,000USD30,132,000USD72,027,000USD60,691,000USD42,582,000USD
    End Period Cash Flow21,620,000USD45,777,000USD33,027,000USD10,462,000USD9,006,000USD30,132,000USD72,027,000USD60,691,000USD
    Other Cashflows From Financing Activities23,975,000USD-3,407,000USD-2,000,000USD-3,171,000USD137,000USD1,650,000USD1,141,000USD410,000USD
    Unclassified Investing Cash Flow-15,502,000USD17,145,000USD62,239,000USD23,160,000USD—-2,597,000USD12,356,000USD—
    Unclassified Financing Cash Flow-24,842,000USD-4,608,000USD—3,171,000USD—-1,650,000USD-1,141,000USD—
    Issuance Of Capital Stock—0USD0USD139,282,000USD0USD70,207,000USD59,996,000USD43,425,000USD
    Other Cashflows From Investing Activities—-2,882,000USD-2,106,000USD-63,250,000USD-650,000USD-796,000USD-270,000USD-502,000USD
    Unclassified Operating Cash Flow—-4,736,000USD-1,163,000USD-5,032,000USD-1,128,000USD——-19,095,000USD
    Change To Liabilities———3,135,000USD528,000USD1,997,000USD4,347,000USD-577,000USD
    Sale Purchase Of Stock———139,345,000USD137,000USD71,857,000USD61,137,000USD43,835,000USD
    Cash And Cash Equivalents Changes———837,000USD-20,468,000USD-41,491,000USD11,328,000USD18,109,000USD
    Dividends Paid——————0USD0USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Operating metrics

    No operating metrics are currently published for this company.

    Revenue breakdown

    PeriodDimensionBusiness / regionRevenueCurrencySource
    Q2 2026Quarterly · 2026-06-30GeographyInternational15,717,000USDDisclosure
    Q2 2026Quarterly · 2026-06-30GeographyUnited States54,791,000USDDisclosure
    Q2 2026Quarterly · 2026-06-30ProductSpine16,876,000USDDisclosure
    Q2 2026Quarterly · 2026-06-30ProductSports Medicine And Other1,000,000USDDisclosure
    Q2 2026Quarterly · 2026-06-30ProductTrauma And Deformity52,632,000USDDisclosure
    Q1 2026Quarterly · 2026-03-31GeographyInternational14,053,000USD0001425450-26-000036
    Q1 2026Quarterly · 2026-03-31GeographyUnited States45,309,000USD0001425450-26-000036
    Q1 2026Quarterly · 2026-03-31ProductSpine15,442,000USD0001425450-26-000036
    Q1 2026Quarterly · 2026-03-31ProductSports Medicine And Other875,000USD0001425450-26-000036
    Q1 2026Quarterly · 2026-03-31ProductTrauma And Deformity43,045,000USD0001425450-26-000036
    Q4 2025Quarterly · 2025-12-31GeographyInternational12,958,000USDLegacy provider
    Q4 2025Quarterly · 2025-12-31GeographyUnited States48,647,000USDLegacy provider
    FY 2025Yearly · 2025-12-31GeographyInternational49,945,000USD0001425450-26-000013
    FY 2025Yearly · 2025-12-31GeographyUnited States186,403,000USD0001425450-26-000013
    FY 2025Yearly · 2025-12-31ProductSpine66,047,000USD0001425450-26-000013
    FY 2025Yearly · 2025-12-31ProductSports Medicine And Other4,000,000USD0001425450-26-000013
    FY 2025Yearly · 2025-12-31ProductTraumaand Deformity166,301,000USD0001425450-26-000013
    Q3 2025Quarterly · 2025-09-30GeographyInternational12,532,000USD0001425450-25-000114
    Q3 2025Quarterly · 2025-09-30GeographyUnited States48,718,000USD0001425450-25-000114
    Q3 2025Quarterly · 2025-09-30ProductSpine16,261,000USD0001425450-25-000114
    Q3 2025Quarterly · 2025-09-30ProductSports Medicine And Other846,000USD0001425450-25-000114
    Q3 2025Quarterly · 2025-09-30ProductTrauma And Deformity44,143,000USD0001425450-25-000114
    Q2 2025Quarterly · 2025-06-30GeographyInternational12,935,000USD0001425450-25-000096
    Q2 2025Quarterly · 2025-06-30GeographyUnited States48,147,000USD0001425450-25-000096
    Q2 2025Quarterly · 2025-06-30ProductSpine18,522,000USD0001425450-25-000096
    Q2 2025Quarterly · 2025-06-30ProductSports Medicine And Other905,000USD0001425450-25-000096
    Q2 2025Quarterly · 2025-06-30ProductTrauma And Deformity41,655,000USD0001425450-25-000096
    Q1 2025Quarterly · 2025-03-31GeographyInternational11,520,000USD0001425450-26-000036
    Q1 2025Quarterly · 2025-03-31GeographyUnited States40,891,000USD0001425450-26-000036
    Q1 2025Quarterly · 2025-03-31ProductSpine13,664,000USD0001425450-26-000036
    Q1 2025Quarterly · 2025-03-31ProductSports Medicine And Other880,000USD0001425450-26-000036
    Q1 2025Quarterly · 2025-03-31ProductTrauma And Deformity37,867,000USD0001425450-26-000036
    Q4 2024Quarterly · 2024-12-31GeographyInternational9,772,000USDLegacy provider
    Q4 2024Quarterly · 2024-12-31GeographyUnited States42,895,000USDLegacy provider
    FY 2024Yearly · 2024-12-31GeographyInternational43,564,000USD0001425450-26-000013
    FY 2024Yearly · 2024-12-31GeographyUnited States161,163,000USD0001425450-26-000013
    FY 2024Yearly · 2024-12-31ProductSpine55,153,000USD0001425450-26-000013
    FY 2024Yearly · 2024-12-31ProductSports Medicine And Other4,448,000USD0001425450-26-000013
    FY 2024Yearly · 2024-12-31ProductTraumaand Deformity145,126,000USD0001425450-26-000013
    Q3 2024Quarterly · 2024-09-30GeographyInternational11,859,000USD0001425450-25-000114
    Q3 2024Quarterly · 2024-09-30GeographyUnited States42,714,000USD0001425450-25-000114
    Q3 2024Quarterly · 2024-09-30ProductSpine15,635,000USD0001425450-25-000114
    Q3 2024Quarterly · 2024-09-30ProductSports Medicine And Other1,296,000USD0001425450-25-000114
    Q3 2024Quarterly · 2024-09-30ProductTrauma And Deformity37,642,000USD0001425450-25-000114
    Q2 2024Quarterly · 2024-06-30ProductSpine13,682,000USD0001425450-25-000096
    Q2 2024Quarterly · 2024-06-30ProductSports Medicine And Other1,349,000USD0001425450-25-000096
    Q2 2024Quarterly · 2024-06-30ProductTrauma And Deformity37,771,000USD0001425450-25-000096
    Q1 2024Quarterly · 2024-03-31ProductSpine10,203,000USD0001425450-25-000052
    Q1 2024Quarterly · 2024-03-31ProductSports Medicine And Other1,180,000USD0001425450-25-000052
    Q1 2024Quarterly · 2024-03-31ProductTrauma And Deformity33,302,000USD0001425450-25-000052
    FY 2023Yearly · 2023-12-31GeographyInternational37,722,000USD0001425450-26-000013
    FY 2023Yearly · 2023-12-31GeographyUnited States111,010,000USD0001425450-26-000013
    FY 2023Yearly · 2023-12-31ProductSpine37,933,000USD0001425450-26-000013
    FY 2023Yearly · 2023-12-31ProductSports Medicine And Other4,018,000USD0001425450-26-000013
    FY 2023Yearly · 2023-12-31ProductTraumaand Deformity106,781,000USD0001425450-26-000013
    FY 2022Yearly · 2022-12-31GeographyInternational29,870,000USD0001425450-25-000015
    FY 2022Yearly · 2022-12-31GeographyUnited States92,419,000USD0001425450-25-000015
    FY 2022Yearly · 2022-12-31ProductACLReconstructionand Other3,806,000USD0001425450-25-000015
    FY 2022Yearly · 2022-12-31ProductSpine33,428,000USD0001425450-25-000015
    FY 2022Yearly · 2022-12-31ProductTraumaand Deformity85,055,000USD0001425450-25-000015
    FY 2021Yearly · 2021-12-31GeographyInternational20,268,000USD0001425450-24-000013
    FY 2021Yearly · 2021-12-31GeographyUnited States77,781,000USD0001425450-24-000013
    FY 2021Yearly · 2021-12-31ProductACLReconstructionand Other4,174,000USD0001425450-24-000013
    FY 2021Yearly · 2021-12-31ProductSpine28,046,000USD0001425450-24-000013
    FY 2021Yearly · 2021-12-31ProductTraumaand Deformity65,829,000USD0001425450-24-000013
    FY 2020Yearly · 2020-12-31GeographyInternational8,112,000USD0001425450-23-000024
    FY 2020Yearly · 2020-12-31GeographyUnited States62,966,000USD0001425450-23-000024
    FY 2020Yearly · 2020-12-31ProductACLReconstructionand Other2,663,000USD0001425450-23-000024
    FY 2020Yearly · 2020-12-31ProductSpine20,738,000USD0001425450-23-000024
    FY 2020Yearly · 2020-12-31ProductTraumaand Deformity47,677,000USD0001425450-23-000024
    FY 2019Yearly · 2019-12-31GeographyInternational17,497,000USD0001425450-22-000027
    FY 2019Yearly · 2019-12-31GeographyUnited States55,055,000USD0001425450-22-000027
    FY 2019Yearly · 2019-12-31ProductACLReconstructionand Other1,696,000USD0001425450-22-000027
    FY 2019Yearly · 2019-12-31ProductSpine21,485,000USD0001425450-22-000027
    FY 2019Yearly · 2019-12-31ProductTraumaand Deformity49,371,000USD0001425450-22-000027
    FY 2018Yearly · 2018-12-31GeographyInternational14,098,000USD0001425450-21-000047
    FY 2018Yearly · 2018-12-31GeographyUnited States43,461,000USD0001425450-21-000047
    FY 2018Yearly · 2018-12-31ProductACLReconstructionand Other1,202,000USD0001425450-21-000047
    FY 2018Yearly · 2018-12-31ProductSpine16,662,000USD0001425450-21-000047
    FY 2018Yearly · 2018-12-31ProductTraumaand Deformity39,695,000USD0001425450-21-000047

    Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.